In cases of adjuvant-induced arthritis, administration of AUR and UMB concurrently with the induction of arthritis showed the ability to reduce serum IL-17 levels, while UMB treatment alone exhibited the capacity to suppress local inflammation [32]. This evidence concerns the gene IL17A and Arthritis.